Zebrafish Models of Rhabdomyosarcoma

Methods in Cell Biology

Volumn 105, Issue , 2011, Pages 383-402

  Chen, Eleanor Y ^a,b   Langenau, David M ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Chemotherapy; Chimeric; Initiation; Malignancy; Oncogenesis; Xenograft

Indexed keywords

EID: 80053206013     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381320-6.00016-3     Document Type: Chapter

References (47)

1. Alcantara Llaguno S., Chen J., Kwon C.H., Jackson E.L., Li Y., Burns D.K., Alvarez-Buylla A., Parada L.F. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009, 15(1):45-56.
2. Banerjee S.S., Eyden B. Divergent differentiation in malignant melanomas: a review. Histopathology 2008, 52(2):119-129.
3. Barr F.G., Galili N., Holick J., Biegel J.A., Rovera G., Emanuel B.S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 1993, 3(2):113-117.
4. Barr F.G., Holick J., Nycum L., Biegel J.A., Emanuel B.S. Localization of the t(2;13) breakpoint of alveolar rhabdomyosarcoma on a physical map of chromosome 2. Genomics 1992, 13(4):1150-1156.
5. Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P., Plasterk R., Zon L.I., Look A.T. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci U S A 2005, 102(2):407-412.
6. Berkes C.A., Tapscott S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 2005, 16(4-5):585-595.
7. Calzada-Wack J., Kappler R., Schnitzbauer U., Richter T., Nathrath M., Rosemann M., Wagner S.N., Hein R., Hahn H. Unbalanced overexpression of the mutant allele in murine Patched mutants. Carcinogenesis 2002, 23(5):727-733.
8. Charafe-Jauffret E., Ginestier C., Birnbaum D. Breast cancer stem cells: tools and models to rely on. BMC Cancer 2009, 9:202.
9. Chen Y., Takita J., Hiwatari M., Igarashi T., Hanada R., Kikuchi A., Hongo T., Taki T., Ogasawara M., Shimada A., Hayashi Y. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies. Genes Chromosomes Cancer 2006, 45(6):583-591.
10. Cornelison D.D., Wold B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 1997, 191(2):270-283.
11. Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., Barr F.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 1994, 54(11):2869-2872.
12. Felix C.A., D'Amico D., Mitsudomi T., Nau M.M., Li F.P., Fraumeni J.F., Cole D.E., McCalla J., Reaman G.H., Whang-Peng J., et al. Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. J Clin Invest 1992, 90(2):653-658.
13. Freeman J.L., Ceol C., Feng H., Langenau D.M., Belair C., Stern H.M., Song A., Paw B.H., Look A.T., Zhou Y., Zon L.I., Lee C. Construction and application of a zebrafish array comparative genomic hybridization platform. Genes Chromosomes Cancer 2009, 48(2):155-170.
14. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher F.J., Emanuel B.S., Rovera G., Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 1993, 5(3):230-235.
15. Gurney J.G., Davis S., Severson R.K., Fang J.Y., Ross J.A., Robison L.L. Trends in cancer incidence among children in the U.S. Cancer 1996, 78(3):532-541.
16. Jessen J.R., Jessen T.N., Vogel S.S., Lin S. Concurrent expression of recombination activating genes 1 and 2 in zebrafish olfactory sensory neurons. Genesis 2001, 29(4):156-162.
17. Kablar B., Krastel K., Tajbakhsh S., Rudnicki M.A. Myf5 and MyoD activation define independent myogenic compartments during embryonic development. Dev Biol 2003, 258(2):307-318.
18. Kappler R., Bauer R., Calzada-Wack J., Rosemann M., Hemmerlein B., Hahn H. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. Oncogene 2004, 23(54):8785-8795.
19. Kawakami K., Shima A., Kawakami N. Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage. Proc Natl Acad Sci U S A 2000, 97(21):11403-11408.
20. Keller C., Arenkiel B.R., Coffin C.M., El-Bardeesy N., DePinho R.A., Capecchi M.R. Alveolar rhabdomyosarcomas in conditional Pax3: Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev 2004, 18(21):2614-2626.
21. Konieczny S.F., Drobes B.L., Menke S.L., Taparowsky E.J. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene. Oncogene 1989, 4(4):473-481.
22. Koufos A., Hansen M.F., Copeland N.G., Jenkins N.A., Lampkin B.C., Cavenee W.K. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature 1985, 316(6026):330-334.
23. Lam S.H., Wu Y.L., Vega V.B., Miller L.D., Spitsbergen J., Tong Y., Zhan H., Govindarajan K.R., Lee S., Mathavan S., Murthy K.R., Buhler D.R., Liu E.T., Gong Z. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 2006, 24(1):73-75.
24. Langenau D.M., Keefe M.D., et al. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 2007, 21(11):1382-1395.
25. Langenau D.M., Keefe M.D., Storer N.Y., Jette C.A., Smith A.C., Ceol C.J., Bourque C., Look A.T., Zon L.I. Co-injection strategies to modify radiation sensitivity and tumor initiation in transgenic Zebrafish. Oncogene 2008, 27(30):4242-4248.
26. Langenau D.M., Traver D., Ferrando A.A., Kutok J.L., Aster J.C., Kanki J.P., Lin S., Prochownik E., Trede N.S., Zon L.I., Look A.T. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003, 299(5608):887-890.
27. Lassar A.B., Thayer M.J., Overell R.W., Weintraub H. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 1989, 58(4):659-667.
28. Le X., Langenau D.M., Keefe M.D., Kutok J.L., Neuberg D.S., Zon L.I. Heat shock-inducible Cre/Lox approaches to induce diverse types of tumors and hyperplasia in transgenic zebrafish. Proc Natl Acad Sci U S A 2007, 104(22):9410-9415.
29. Lee Y., Kawagoe R., Sasai K., Li Y., Russell H.R., Curran T., McKinnon P.J. Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 2007, 26(44):6442-6447.
30. Linardic C.M., Downie D.L., Qualman S., Bentley R.C., Counter C.M. Genetic modeling of human rhabdomyosarcoma. Cancer Res 2005, 65(11):4490-4495.
31. Mao J., Ligon K.L., Rakhlin E.Y., Thayer S.P., Bronson R.T., Rowitch D., McMahon A.P. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res 2006, 66(20):10171-10178.
32. McKinnell I.W., Ishibashi J., Le Grand F., Punch V.G., Addicks G.C., Greenblatt J.F., Dilworth F.J., Rudnicki M.A. Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat Cell Biol 2008, 10(1):77-84.
33. Mulligan L.M., Matlashewski G.J., Scrable H.J., Cavenee W.K. Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci U S A 1990, 87(15):5863-5867.
34. Nanni P., Nicoletti G., De Giovanni C., Croci S., Astolfi A., Landuzzi L., Di Carlo E., Iezzi M., Musiani P., Lollini P.L. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Cancer Res 2003, 63(11):2728-2732.
35. Ramaswamy S., Tamayo P., Rifkin R., Mukherjee S., Yeang C.H., Angelo M., Ladd C., Reich M., Latulippe E., Mesirov J.P., Poggio T., Gerald W., Loda M., Lander E.S., Golub T.R. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001, 98(26):15149-15154.
36. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111.
37. Santoriello C, Deflorian G., Pezzimenti F., Kawakami K., Lanfrancone L., d'Adda di Fagagna F., Mione M. Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells. Dis Model Mech 2009, 2(1-2):56-67.
38. Scrable H.J., Witte D.P., Lampkin B.C., Cavenee W.K. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 1987, 329(6140):645-647.
39. Sharp R., Recio J.A., Jhappan C., Otsuka T., Liu S., Yu Y., Liu W., Anver M., Navid F., Helman L.J., DePinho R.A., Merlino G. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat Med 2002, 8(11):1276-1280.
40. Smith A.C., Raimondi A.R., Salthouse C.D., Ignatius M.S., Blackburn J.S., Mizgirev I.V., Storer N.Y., de Jong J.L., Chen A.T., Zhou Y., Revskoy S., Zon L.I., Langenau D.M. High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia. Blood 2010, 115(16):3296-3303.
41. Stratton M.R., Fisher C., Gusterson B.A., Cooper C.S. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res 1989, 49(22):6324-6327.
42. Stratton M.R., Moss S., Warren W., Patterson H., Clark J., Fisher C., Fletcher C.D., Ball A., Thomas M., Gusterson B.A., et al. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene 1990, 5(9):1297-1301.
43. Sweet-Cordero A., Mukherjee S., Subramanian A., You H., Roix J.J., Ladd-Acosta C., Mesirov J., Golub T.R., Jacks T. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat Genet 2005, 37(1):48-55.
44. Todaro M., Francipane M.G., Medema J.P., Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010, 138(6):2151-2162.
45. Tsumura H., Yoshida T., Saito H., Imanaka-Yoshida K., Suzuki N. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice. Oncogene 2006, 25(59):7673-7679.
46. Weintraub H., Dwarki V.J., Verma I., Davis R., Hollenberg S., Snider L., Lassar A., Tapscott S.J. Muscle-specific transcriptional activation by MyoD. Genes Dev 1991, 5(8):1377-1386.
47. Williamson D., Missiaglia E., de Reynies A., Pierron G., Thuille B., Palenzuela G., Thway K., Orbach D., Lae M., Freneaux P., Pritchard-Jones K., Oberlin O., Shipley J., Delattre O. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol 2010, 28(13):2151-2158.